Responses
Clinical and epidemiological research
Extended report
Maintenance of biologic-free remission with naproxen or no treatment in patients with early, active axial spondyloarthritis: results from a 6-month, randomised, open-label follow-up study, INFAST Part 2
Compose a Response to This Article
Other responses
No responses have been published for this article.